Mattia Dessena

Contacts

High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease

Authors: Toscani D.; Lungu O.; Chiu M.; Maccari C.; Raimondi V.; Taurino G.; Bianchi M. G.; Scita M.; Dalla Palma B.; Iannozzi N. T.; Vescovini R.; Dessena M.; Sitzia C.; Storti P.; Andreoli R.; Bussolati O.; Giuliani N.

Year: 2025
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients

Authors: Raimondi V.; Storti P.; Vescovini R.; Franceschi V.; Toscani D.; Notarfranchi L.; Dalla Palma A. B.; Iannozzi N. T.; Minesso S.; Scita M.; Lungu O.; Dessena M.; Donofrio G.; Giuliani N.

Year: 2025
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients

Authors: Raimondi V.; Vescovini R.; Dessena M.; Donofrio G.; Storti P.; Giuliani N.

Year: 2024
Loss of embryonically-derived Kupffer cells during hypercholesterolemia accelerates atherosclerosis development

Authors: Fima Rebecca; Dussaud Sébastien; Benbida Cheïma; Blanchet Margault; Lanthiez François; Poupel Lucie; Brambilla Claudia; Gélineau Adélaïde; Dessena Mattia; Blanc Marina; Lerévérend Cédric; Moreau Martine; Boissonnas Alexandre; Gautier Emmanuel L.; Huby Thierry

Year: 2024
In vitro evaluation of the immunomodulatory activity of the nutraceutical formulation AminoDefence

Authors: Papotti B; Dessena M; Adorni Mp; Paleari D; Rinaldi L; Bernini F.

Year: 2024